• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP Back to Search Results
Catalog Number JHJR062502J
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Occlusion (1984); Claudication (2550)
Event Date 12/01/2018
Event Type  Injury  
Manufacturer Narrative
Literature citation: a case of acute occlusion of viabahn, okinawa medical journal, volume 57, number 3, page 83 (published in december 2018).Additional devices involved in event: jhr060502j no lot number or udi available and jhjr060202j no lot number or udi available.A review of the manufacturing records could not be conducted since the requested lot numbers remain unknown.
 
Event Description
The following publication was reviewed: a case of acute occlusion of viabahn on an unknown date, a (b)(6) year old female underwent endovascular repair for chronic total occlusion (cto) of the left superficial femoral artery using gore® viabahn® endoprosthesis with heparin bioactive surface.A 6.0 mm x 2.5 cm viabahn was implanted distally, and 6.0 mm x 5 cm viabahn was implanted proximally.During post ballooning, a dissection was noted at the distal portion of the endoprosthesis, so an additional 6.0 mm x 2.5 cm viabahn was implanted to repair the dissection.Good blood flow was observed, and the patient tolerated the procedure.Nine days after the initial procedure was performed, the patient exhibited numbness of the left leg.Ten days after the initial procedure the patient experienced pain in the left leg when walking only two or three meters.The patient presented to the hospital, and it was confirmed that the left leg was cold and the left popliteal and dorsal arteries were impalpable.Therefore, an emergent thrombectomy with a fogarty catheter was performed for acute occlusion of the endoprostheses.Blood flow was restored, and occlusion was no longer observed.
 
Manufacturer Narrative
Patient identifier updated.
 
Manufacturer Narrative
Literature article attached.- attachment: [literature article event # 40141.Pdf].
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key8512505
MDR Text Key141910414
Report Number2017233-2019-00247
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup,Followup
Report Date 07/09/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/13/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberJHJR062502J
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Other; Required Intervention;
Patient Age66 YR
-
-